Velpatasvir (Molecule of the Month for May 2017)
Velpatasvir is amedication used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus. Velpatasvir is an NS5A inhibitor which is used together with sofosbuvir in the treatment of hepatitis C infection of all six major genotypes.
The substance blocks NS5A, a protein necessary for hepatitis C virus replication and assembly
Formal Chemical Name (IUPAC)
methyl ((S)-1-((2S,5S)-2-(9-(2-((2S,4S)-1-((R)-2-((methoxycarbonyl)amino)-2-phenylacetyl)-4-(methoxymethyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho
References
click on the picture of Velpatasvir above to interact
with the 3D model of the
Velpatasvir structure
(this will open a new browser window)
C49H54N8O8
Update by Karl Harrison
(Molecule of the Month for
May 2017
)
All the images on this web site are are made available with a Creative Commons Attribution license and so can be used as long as the attribution © Karl Harrison 3DChem.com is written with the image. High resolution images and illustrations are available on request.